Purine derivatives as A3 and A1 adenosine receptor agonists

Details for Australian Patent Application No. 2005285284 (hide)

Owner Government of The United States of America, Represented by the Secretary, Department of Health and Human Services

Inventors Tchilibon, Susanna; Joshi, Bhalchandra V.; Jacobson, Kenneth A.

Agent Fisher Adams Kelly

Pub. Number AU-B-2005285284

PCT Pub. Number WO2006/031505

Priority 60/608,823 09.09.04 US

Filing date 2 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 2 June 2011

International Classifications

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/031505 Priority application(s): WO2006/031505

2 June 2011 Application Accepted

  Published as AU-B-2005285284

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005285286-Light management film and its preparation and use

2005285279-Reconstituting infusion device